Molecular Decisions Inc.
No Reviews Yet
No Completed Orders
San Carlos, California, US
Although measuring DNA, RNA or proteins has the appeal of being operationally straightforward, it is often inadequate since specific protein modifications are frequently the relevant indicators of a disease state or therapeutic response of interest. Molecular Decisions, brings sophisticated proteomics to bear to enable a new generation of more effective therapeutics and diagnostics.
A new generation of therapeutics and diagnostics that dramatically reduce patient suffering.
Molecular Decisions delivers on the promise of proteomics.
Molecular Decisions provides services to pharmaceutical companies, helping them do faster and more confident drug development and clinical trials. The company analyzes clinical or analytical samples using nanoimmunoassays that precisely measure specific protein isoform drug targets, enabling sound, immediate decisions related to drug efficacy.
Molecular Decisions provides boutique CRO services to pharmaceutical companies, helping them do faster and more confident drug development and clinical trials. The company analyzes clinical or analytical samples using nanoimmunoassays that precisely measure specific protein isoform drug targets, enabling sound, immediate decisions related to drug efficacy.
Molecular Decisions provides boutique CRO services to pharmaceutical companies, helping them do faster and more confident drug development and clinical trials. The company analyzes clinical or analytical samples using nanoimmunoassays that precisely measure specific protein isoform drug targets, enabling sound, immediate decisions related to drug efficacy.
We assist clients in developing or refining assays.
Molecular Decisions’ expertise complements the internal resources of clients to help develop their assays or to expand their assay candidates to include specific protein isoforms.
The company has validated tests for a number of cancer targets. We have developed independent protein assays for kidney, lung, ovarian, breast, endometrial, lymphoma, leukemia and myelodysplasia.
Molecular Decisions Inc. has not received any reviews.
Molecular Decisions Inc. has not received any endorsements.